SCHEDULE: Danone Halts Lifeway Foods Acquisition Talks

Danone North America PBC has ceased its pursuit of acquiring Lifeway Foods, Inc. after due diligence, now reviewing alternatives for its 22.7% stake.

Summary

• Danone North America PBC (Danone) has terminated its previously disclosed potential acquisition of Lifeway Foods, Inc.
• The decision was made on September 17, 2025, after Danone's due diligence review failed to confirm its previous acquisition proposal.
• Danone is now evaluating alternatives for its 3,454,756 shares, representing a 22.7% stake, in Lifeway.
• These alternatives include selling all or part of its investment, continuing to hold the shares, or changing its strategic intentions.
• Danone is also considering whether to vote its shares in favor of Edward Smolyansky's proposals to replace the entire Lifeway Board of Directors.
• Danone S.A. indirectly beneficially owns the shares held by its wholly-owned subsidiary, Danone North America PBC.
• Danone disputes the validity of certain outstanding shares, specifically those purportedly issued to Julie Smolyansky or her spouse without its consent.

Sentiment

Score: 3

Explanation: The sentiment is negative due to the termination of acquisition discussions, which often signals underlying issues or a lack of alignment. The uncertainty surrounding Danone's significant stake and the potential for a proxy battle further contribute to a negative outlook for Lifeway Foods.

Positives

• Danone's decision to cease the acquisition pursuit indicates a disciplined approach to capital allocation, avoiding a deal that did not confirm its initial proposal.

Negatives

• Danone's decision to no longer pursue the acquisition of Lifeway Foods, Inc.
• The inability to confirm the previous acquisition proposal during due diligence.
• Uncertainty regarding Danone's future investment in Lifeway, including potential divestment.
• The dispute over the validity of certain outstanding shares, including those purportedly issued to Julie Smolyansky or her spouse, suggests internal governance issues or disagreements.

Risks

• Uncertainty surrounding Danone's 22.7% investment in Lifeway, including the possibility of a full or partial divestment.
• Potential for a proxy contest or board changes if Danone supports Edward Smolyansky's proposals to replace the entire Lifeway Board of Directors.
• Dispute over the validity of certain outstanding shares, potentially leading to legal challenges or governance instability.
• The failure of the acquisition talks could negatively impact Lifeway's stock price and strategic direction.

Future Outlook

Danone is reviewing alternatives for its investment in Lifeway, which could include selling all or part of its stake, continuing to hold it, or changing its strategic intentions. It is also considering supporting a proposal to replace Lifeway's entire Board of Directors.

Management Comments

• "In the course of our due diligence review of Lifeway, we were not able to confirm our previous proposal to acquire Lifeway."
• "We determined on September 17, 2025 to no longer pursue an acquisition of Lifeway, and informed Lifeway of such on the same date."
• "We are now in the process of reviewing alternatives for our investment in Lifeway."
• "As part of this review of alternatives for our investment in Lifeway, we are also reviewing whether to vote the shares of Common Stock we own in favor of Edward Smolyansky's proposals set forth in his pending consent solicitation statement to replace the entire Lifeway Board of Directors, and we have not yet made a final decision in this regard."
• "As part of our review, we may in the future take such actions with respect to our investment in Lifeway as we deem appropriate, including, without limitation, selling all or part of our investment in Lifeway, continuing to hold our investment in Lifeway or changing our intention with respect to any and all matters referred to in Item 4 of Schedule 13D."
• "The reporting persons do not hereby concede that all such reported outstanding shares are validly issued and outstanding, including, without limitation, any shares purported to have been issued to Julie Smolyansky or her spouse without the consent of Danone North America PBC."

Industry Context

The food and beverage industry, particularly the dairy and cultured products segment (kefir, yogurt), is competitive. Consolidation attempts and strategic investments are common as companies seek market share and operational efficiencies. Danone's decision to withdraw from an acquisition highlights the rigorous due diligence processes in M&A, especially in a mature industry where synergies and financial viability are critical. The mention of a potential proxy fight also points to ongoing corporate governance challenges that can arise in companies with significant institutional investors.

Corporate Governance

Legal Proceedings

• The filing mentions a dispute regarding the validity of certain outstanding shares, specifically those purportedly issued to Julie Smolyansky or her spouse without Danone North America PBC's consent. This implies a potential for future legal proceedings or existing disagreements.

Related Party Transactions

• Dispute over the validity of shares purportedly issued to Julie Smolyansky or her spouse without Danone North America PBC's consent, suggesting a potential related party issue.

Stakeholder Impact

• Shareholders: Increased uncertainty regarding Lifeway's future, potential stock price volatility due to the terminated acquisition and possible divestment by Danone, and potential for a proxy fight.
• Management/Board: Potential for significant changes if Danone supports the proposal to replace the entire Board of Directors.
• Employees: Potential for strategic shifts or changes in company direction depending on future ownership and governance.
• Customers/Suppliers: Indirect impact from potential strategic changes or shifts in company focus.

Next Steps

• Danone will continue reviewing alternatives for its investment in Lifeway Foods, including potential sale, continued holding, or changes in strategic intent.
• Danone will decide whether to vote its shares in favor of Edward Smolyansky's proposals to replace the entire Lifeway Board of Directors.

Key Dates

Recommendation

The termination of acquisition talks by a significant strategic investor like Danone, coupled with Danone's explicit review of divesting its 22.7% stake and considering supporting a full board replacement, signals significant negative developments for Lifeway Foods. This creates substantial uncertainty, potential for stock price decline due to a large block sale, and likely corporate instability. A seasoned investor would likely view this as a strong signal to exit or reduce exposure.

Keywords

Lifeway Foods, Danone, acquisition, Schedule 13D, investment, common stock, beneficial ownership, corporate governance, proxy fight, due diligence, divestment, food industry, dairy, kefir